Medicine Description metrovent 25mcg
Metrovent 25mcg Inhalation is a medication that primarily contains fluticasone propionate, a synthetic corticosteroid. Its mechanism of action involves the modulation of inflammatory responses in the airways. Fluticasone propionate binds to glucocorticoid receptors in airway epithelial cells, leading to the inhibition of pro-inflammatory cytokines, chemokines, and other inflammatory mediators. This results in a reduction of airway inflammation and edema, ultimately improving airflow and reducing symptoms of asthma and chronic obstructive pulmonary disease (COPD). Additionally, fluticasone propionate decreases the infiltration of inflammatory cells into the airways, thereby exerting a long-lasting anti-inflammatory effect. The medication also enhances the responsiveness of beta-adrenergic receptors, improving bronchodilation in response to beta-agonists when used in conjunction.
Indications and Uses of Metrovent 25mcg Inhalation
- Management of asthma in patients requiring prolonged anti-inflammatory therapy.
- Management of chronic obstructive pulmonary disease (COPD) to reduce symptoms and frequency of exacerbations.
- As a preventative treatment for exercise-induced bronchoconstriction.
Side Effects of Metrovent 25mcg Inhalation
- Oral thrush (candidiasis)
- Hoarseness of voice
- Throat irritation
- Headache
- Increased risk of pneumonia in COPD patients
- Adrenal suppression with prolonged use
Storage and Handling
Store at room temperature, away from moisture and heat. Keep the inhaler tightly closed when not in use. Do not freeze.
Patient Advice and Precautions
Ensure proper inhalation technique to maximize drug delivery. Rinse your mouth after each use to reduce the risk of oral thrush. Regularly schedule follow-up appointments to monitor lung function and adjust treatment as necessary. Be aware of any new symptoms, particularly signs of infection or worsening respiratory issues, and report them to your healthcare provider promptly.